Published in
Elsevier, European Journal of Cancer, (143), p. 55-63, 2021
DOI: 10.1016/j.ejca.2020.10.027
Links
Tools
Triplet combination of durvalumab, tremelimumab, and paclitaxel in biliary tract carcinomas: Safety run-in results of the randomized IMMUNOBIL PRODIGE 57 phase II trial
Journal article published in 2021 by
Alice Boilève,
Marc Hilmi 
,
Paul Gougis,
Romain Cohen,
Benoît Rousseau ,
Jean-Frédéric Blanc,
Meher Ben Abdelghani,
Hélène Castanié,
Laëtitia Dahan,
David Tougeron,
Jean-Philippe Metges,
Christophe Tournigand,
Marie-Line Garcia-Larnicol,
Dewi Vernerey,
Anthony Turpin
and other authors.
,
Paul Gougis,
Romain Cohen,
Benoît Rousseau ,
Jean-Frédéric Blanc,
Meher Ben Abdelghani,
Hélène Castanié,
Laëtitia Dahan,
David Tougeron,
Jean-Philippe Metges,
Christophe Tournigand,
Marie-Line Garcia-Larnicol,
Dewi Vernerey,
Anthony Turpin
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 